← Back to Clinical Trials
Recruiting NCT06804694

NCT06804694 Technology-Enabled Collaborative Care for Young Adults With Type 1 Diabetes and Diabetes Distress: A Feasibility Trial

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06804694
Status Recruiting
Phase —
Sponsor Centre for Addiction and Mental Health
Condition Type 1 Diabetes (T1D)
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2024-11-27
Primary Completion 2025-09

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 29 Years
Study Type INTERVENTIONAL
Interventions
TECC-T1D3 ProgramEducation Intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2024-11-27 with a primary completion date of 2025-09.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of the study is to evaluate the acceptability and feasibility of a co-designed, Technology-Enabled Collaborative Care for Young Adults with Type-1 Diabetes and Diabetes Distress (TECC-T1D3) program. Through this program, the investigators aim to deliver a collaborative care intervention, featuring a health coach and a virtual care team, designed to help participants manage mental health and overall wellbeing.

Eligibility Criteria

Inclusion Criteria: * Young adult (age 18-29 years) * Resident of Ontario * Living with a self-reported diagnosis of T1D of at least 1 year * Individual is community-living (people who live independently in the community and are not residing in a setting that provide institutional care or support) Exclusion Criteria: * Unable to participate in English language * Unable to participate via telephone or web-conferencing

Contact & Investigator

Central Contact

Anika Saiva, MPH

✉ anika.saiva@camh.ca

📞 (416) 535-8501

Principal Investigator

Peter Selby

PRINCIPAL INVESTIGATOR

Centre for Addiction and Mental Health

Frequently Asked Questions

Who can join the NCT06804694 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 29 Years, studying Type 1 Diabetes (T1D). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06804694 currently recruiting?

Yes, NCT06804694 is actively recruiting participants. Contact the research team at anika.saiva@camh.ca for enrollment information.

Where is the NCT06804694 trial being conducted?

This trial is being conducted at Toronto, Canada.

Who is sponsoring the NCT06804694 clinical trial?

NCT06804694 is sponsored by Centre for Addiction and Mental Health. The principal investigator is Peter Selby at Centre for Addiction and Mental Health. The trial plans to enroll 60 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology